Clinical Trial Update: Safety Study of Tetrathiomolybdate in Patients With Idiopathic Pulmonary Fibrosis [Phase 1, Phase 2]

View source ↗

Summary

This document notes the completion of a Phase 1/2 safety study of tetrathiomolybdate in patients with idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Tetrathiomolybdate (tetrathiomolybdate)

Snippet

Sponsor: University of Michigan | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1, Phase 2 | Status: COMPLETED